What is the main business of Almirall?

The main business activity of Almirall focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on October 31, 2007.

Where is the headquarters located?

The headquarters is located at: Pileckiego 63, 02-781 Warszawa.

What is the share capital?

The share capital of the company is PLN 50,500 (approx. $13,641).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

How much revenue was generated?

In 2025, the company generated total revenue of USD 2,488,511, representing an increase of 23.9% compared to 2024.

Yes, the company recorded a net profit of USD 76,944 in 2025, meaning the company increased its profit by 29.6%.

What is the main operating cost?

The largest operating cost category falls under other operating costs. This category amounted to USD 875,507 in 2025, representing 36% of all operating expenses.

Almirallsp. z o.o.

Development, manufacture and distribution of medicines and pharmaceutical products, and other related activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2007-10-31

Share capital

50 500,00 PLN

Activity description

Almirall develops and supplies pharmaceutical products for skin conditions, investing in research and development. Its portfolio includes Aknemycin ointment, solution and Plus, as well as Skilarence and Aknenormin; its products are available in more than 70 countries.

Registered address

Pileckiego 63, 02-781 Warszawa, Poland

Website

almirall.pl

Phone

Electronic delivery address

AE:PL-57271-59630-EIEBF-22

Financials

2 of the last 5 financial statements were filed late.

Revenue history (in k)

Financial insight

Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs voivodeship

Revenue

This companyUSD 2.49mMedianUSD 156.49kAverageUSD 5.73m

Net profit

This companyUSD 76.94kMedianUSD 2.42kAverageUSD 291.89k

Operating costs

This companyUSD 2.40mMedianUSD 131.45kAverageUSD 4.94m

Assets

This companyUSD 2.42mMedianUSD 163.40kAverageUSD 10.69m

Industry

Development, manufacture and distribution of medicines and pharmaceutical products, and other related activities (21.20.Z)Primary
Development, manufacture and distribution of cosmetics, and other related activities (20.42.Z)
Wholesale of perfume and cosmetics (46.45.Z)

Bank accounts

Registered as a VAT taxpayer on 2007-09-19.

Deutsche Bank Polska
60 1880 0009 0000 0011 0178 1000

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Authorized Representatives

Agnieszka Maria Rączewska – Attorney-in-fact (joint)

David Guinart Carvajal – Attorney-in-fact (joint)

Esteban Conesa Panicot – Management Board Member

Cristina Ponce Moreno – Attorney-in-fact (joint)

Peter Dangel – Attorney-in-fact (joint)

Manner of representation

Each member of the company's management board has the right to represent the company independently.

Ownership

Owner	Shares	Share value	Stake
Almirall Holding Iberia S.l.	101	$13,641.27	100%

Beneficial owners

Person	Rights

Competitors

Name	Revenue	Website
Fagronsp. z o.o.	$21,715,187.73	fagron.pl
Przedsiębiorstwo Farmaceutyczne Farmapolsp. z o.o.	$21,462,728.43	farmapol.pl
Actifarmsp. z o.o.	$2,151,476.85	actifarm.pl

Change history

Date	Event
2009-05-26	Share capital change (50,000.00 PLN → 50,500.00 PLN)
2009-01-14	Address change (Rzymowskiego 53/302, 02-697, Warszawa → Pileckiego 63, 02-781, Warszawa)
2008-02-15	Address change (Plac Piłsudskiego 1, 00-078, Warszawa → Rzymowskiego 53/302, 02-697, Warszawa)
2008-02-15	Name change (Pumila → Almirall)
2008-02-15	PKD change (Removed: 51.90.Z, 52.12.Z, 65.21.Z, 65.22.Z, 65.23.Z, 67.13.Z, 70.11.Z, 70.12.Z, 70.20.Z, 70.32.Z, 72.30.Z, 72.40.Z, 74.13.Z, 74.14.A, 74.15.Z, 74.40.Z, 74.87.B; Added: 20.42.Z, 21.20.Z, 46.45.Z, 46.46.Z, 47.73.Z, 47.74.Z, 47.75.Z)

FAQ

Last updated: 2026-10-02